Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
Anand K Deva, Suzanne D Turner, Marshall E Kadin, Mark R Magnusson, H Miles Prince, Roberto N Miranda, Giorgio G Inghirami, William P Adams
Cancers | MDPI | Published : 2020
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a CD30-positive, anaplastic lymphoma kinase-negative T-cell lymphoma. Where implant history is known, all confirmed cases to date have occurred in patients with exposure to textured implants. There is a spectrum of disease presentation, with the most common occurring as a seroma with an indolent course. A less common presentation occurs as locally advanced or, rarely, as metastatic disease. Here we review the immunological characteristics of BIA-ALCL and potential triggers leading to its development. BIA-ALCL occurs in an inflammatory microenvironment with significant lymphocyte and plasma cell infiltration and a prominen..View full abstract
This research was funded by Allergan plc, Dublin, Ireland (prior to its acquisition by AbbVie).